These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3877710)

  • 1. [Circumscribed scleroderma: internal manifestations and significant correlation to HLA-DR1 and DR5].
    Luderschmidt C; König G; Leisner B; Scholz S; Albert EE
    Hautarzt; 1985 Sep; 36(9):516-21. PubMed ID: 3877710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of HLA antigens with scleroderma].
    Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
    Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
    Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE
    J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen specificity of antihistone antibodies in localized scleroderma.
    Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese.
    Fujita K; Naito S; Okabe N; Yao T
    J Clin Lab Immunol; 1984 Jun; 14(2):99-102. PubMed ID: 6611420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research].
    Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disabling pansclerotic morphea of children.
    Diaz-Perez JL; Connolly SM; Winkelmann RK
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized scleroderma in childhood is not just a skin disease.
    Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
    Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].
    Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Belmonte López MA; García Portales R; Frutos Sanz MA; Guil García M; de Ramón Garrido E
    Med Clin (Barc); 1994 May; 102(18):688-93. PubMed ID: 8028418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
    Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
    J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.